All research protocols that propose the use of recombinant DNA must receive prior approval from the Institutional Biosafety Committee.

Guidance Documents:

• IBC Meeting Schedule and Submission Deadlines
• IBC Guidelines for Investigators 
• Summary of NIH Approval Categories (Section III)
• Biosafety Considerations for Research with Lentiviral Vectors  

Forms: 

Each time you fill out a new form, please download it from this website. These forms will be updated periodically.

• Recombinant DNA Exemption Request Form   For III-F Studies
• Recombinant DNA Gene Transfer Form   For III-C, III-D & III-E Studies
• IBC Annual Update and Renewal Form 
• IBC Amendment Form 

Human Gene Transfer Research:

Important Links:

• NIH Guidelines for Research Involving Recombinant DNA
• NIH Office of Biotechnology Activities
• University of Miami Office of Environmental Health & Safety
• OBA Posts Frequently Asked Questions about Research Constituting a "Major Action"

Additional Resources:

• UC Irvine Research Tutorials
• Bio-safety lectures in cell sorting
• Biosafety Considerations for Research with Lentiviral Vectors

Questions?

Please contact the IBC Administrator:

Ellen Kapsalis, Ph.D.
IBC Associate Director
Office of Research
Dominion Tower, Suite 1205F (Locator: R-64)
Phone: (305) 243-2311
Fax: (305) 243-2853